The purpose of this study is to evaluate Venlafaxine as a treatment option for hot flashes in
breast cancer survivors. The goals of this study are to assess the effectiveness and toxicity
of venlafaxine hydrochloride and identify the psychological, behavioral, and physical
outcomes associated with relief of hot flashes in women following treatment for breast
cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Indiana University School of Medicine
Collaborators:
Vanderbilt University Vanderbilt University Medical Center